1293576

Ashley L. Devonshire, M.D., MPH — FEI 3039281824

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance